Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions ...
Bio & Medicine
Mar 4, 2024
0
55
An international team of researchers, led by Professor Gustavo Goldman of the University of São Paulo and Maynooth University's Dr. Özgür Bayram, has unveiled ground-breaking findings on Aspergillus fumigatus, which can ...
Cell & Microbiology
Jan 4, 2024
0
34
Patients struggling with some chronic diseases often must wait years for a proper diagnosis. For example, symptoms such as shortness of breath can be attributed to many pulmonary as well as cardiovascular disorders, so patients ...
Bio & Medicine
Dec 15, 2023
0
33
Research is using ticks to help unlock better ways to fight inflammation, which causes considerable suffering in people globally.
Biochemistry
Jul 18, 2023
0
95
How does an embryo develop? How do children grow, wounds heal or cancer spread? All of this has to do with the growth of body tissue. One of the major research interests of ETH Professor Viola Vogel and her senior assistant ...
Cell & Microbiology
May 3, 2023
0
461
New research uses AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design and synthesis of a drug to treat hepatocellular carcinoma (HCC), the most common type of primary liver ...
Biochemistry
Jan 19, 2023
0
80
Persistent lung infections, chronic wounds, and health care-associated infections are typically much more difficult to treat than other types of bacterial infections. This is because they are often caused by biofilms, that ...
Bio & Medicine
Oct 7, 2022
0
270
A potential new treatment combining natural manuka honey with a widely used drug has been developed by scientists at Aston University to treat a potentially lethal lung infection and greatly reduce side effects of one of ...
Cell & Microbiology
Sep 7, 2022
0
973
Scientists at the University of Illinois Chicago have developed a treatment for pulmonary fibrosis by using nanoparticles coated in mannose—a type of sugar—to stop a population of lung cells called macrophages that contribute ...
Bio & Medicine
Apr 5, 2022
0
408
Telomeres are large nucleoproteins structures that cap the ends of chromosomes in eukaryotic cells. When a cell divides, a small portion of the telomere is lost due to the inherently incomplete process of genome replication. ...
Biotechnology
Apr 22, 2021
0
197
Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs). It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues.
The term ILD is used to distinguish these diseases from obstructive airways diseases.
Most types of ILD involve fibrosis, but this is not essential. The term "pulmonary fibrosis" is no longer considered a synonym. Idiopathic pulmonary fibrosis is one form of "interstitial lung disease".
This text uses material from Wikipedia, licensed under CC BY-SA
